BiovelocITA Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $14.6M

  • Investors
  • 7

BiovelocITA General Information

Description

Provider of business accelerator programs intended to contribute to the growth of the Italian biotechnology market. The company offers venture-building services with scientific collaboration, project planning, funding support, operational management, and access to research expertise, enabling early-stage biotechnology projects and scientific teams to develop therapeutic programs and transition research into commercially viable healthcare applications.

Contact Information

Website
www.biovelocita.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Visconti di Modrone, 18
  • 20122 Milan
  • Italy
+39 02
Primary Industry
Private Equity
Other Industries
Other Healthcare Services
Vertical(s)
FinTech
Corporate Office
  • Via Visconti di Modrone, 18
  • 20122 Milan
  • Italy
+39 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BiovelocITA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 11-Sep-2019 $14.6M Completed Generating Revenue
4. Early Stage VC (Series A) 16-Mar-2017 Completed Generating Revenue
3. Early Stage VC Completed Startup
2. Early Stage VC 31-Mar-2016 $892K $7.48M Completed Startup
1. Seed Round 18-Nov-2015 $6.59M $6.59M Completed Startup
To view BiovelocITA’s complete valuation and funding history, request access »

BiovelocITA Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

BiovelocITA Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021224429-A1 Exosome-anchoring coronavirus fusion proteins and vaccines Inactive 06-May-2020
EP-4146256-A1 Exosome-anchoring fusion proteins and vaccines Inactive 04-May-2020
US-20230173063-A1 Exosome-anchoring fusion proteins and vaccines Inactive 04-May-2020
WO-2021224260-A1 Exosome-anchoring fusion proteins and vaccines Inactive 04-May-2020
WO-2021224260-A9 Exosome-anchoring fusion proteins and vaccines Inactive 04-May-2020 A61K39/385
To view BiovelocITA’s complete patent history, request access »

BiovelocITA Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BiovelocITA Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Banca Profilo Asset Manager Minority
Landmark Capital (Italy) Family Office Minority
Banor Sim Family Office Minority
Indaco Venture Partners Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 7 investors. Get the full list »

BiovelocITA Investments (7)

BiovelocITA’s most recent deal was a Seed Round with Alia Therapeutics for . The deal was made on 17-Apr-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Alia Therapeutics 17-Apr-2023 Seed Round Drug Discovery
Alia Therapeutics 28-May-2021 Seed Round Drug Discovery
Alia Therapeutics 08-Apr-2019 Seed Round Drug Discovery
Enthera 24-Jul-2018 Seed Round Drug Discovery
Amypopharma 12-May-2018 Accelerator/Incubator Biotechnology
You’re viewing 5 of 7 investments. Get the full list »

Ready to get started?

Request a free trial

BiovelocITA FAQs

  • When was BiovelocITA founded?

    BiovelocITA was founded in 2015.

  • Where is BiovelocITA headquartered?

    BiovelocITA is headquartered in Milan, Italy.

  • What is the size of BiovelocITA?

    BiovelocITA has 5 total employees.

  • What industry is BiovelocITA in?

    BiovelocITA’s primary industry is Private Equity.

  • Is BiovelocITA a private or public company?

    BiovelocITA is a Private company.

  • What is BiovelocITA’s current revenue?

    The current revenue for BiovelocITA is .

  • How much funding has BiovelocITA raised over time?

    BiovelocITA has raised $30.4M.

  • Who are BiovelocITA’s investors?

    Banca Profilo, Landmark Capital (Italy), Banor Sim, Indaco Venture Partners, and are 5 of 7 investors who have invested in BiovelocITA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process